Pyxis Oncology, Inc. - 8-K Filing
Pyxis Oncology appointed Thomas Civik as permanent CEO and Chairman, effective September 4, 2026. (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi, 7.01 Regulation FD Disclosure, 9.01 Financial Statements and Exhibits)
Tickers: $PYXS